Search results for:
insulin lispro
insulin lispro
- Formulary Insulin Formulary
- Restricted Utilize most cost-effective agent.
- Non-formulary
- Therapeutic Interchange
Drug Name |
Form |
Strength |
Formulary Unrestricted |
Formulary Restricted |
Non-Formulary |
Interchange |
Admelog SoloStar |
DEVICE, SUBCUTANEOUS |
100 units/mL |
|
|
|
|
Lyumjev |
INJECTION, SUBCUTANEOUS |
100 units/mL |
|
|
|
|
Admelog |
SOLUTION, SUBCUTANEOUS |
100 units/mL |
|
|
|
|
HumaLOG |
SOLUTION, SUBCUTANEOUS |
100 units/mL |
|
|
|
|
Last updated: Sep. 3, 2024
Approved to round DOWN to nearest whole unit if calculations result in dose in fractions.
Patients with orders for the hospital’s adult sliding scale insulin order set have orders to implement the hospital’s hypoglycemia orders. However, some patients have orders for scheduled or PRN insulin without use of the sliding scale insulin order set. These patients may not have PRN orders for treatment of hypoglycemia.
To improve safety with insulin use, the following policy has been approved by the P&T Committee:
Admelog has been classified as therapeutically equivalent to Humalog.
Lyumjev has been classified as therapeutically equivalent to Humalog for ADULT patients.
The most cost-effective insulin lispro product will be used in a specific patient, setting or time period.
Admelog SoloStar is non-formulary. There is an automatic interchange to insulin lispro on a 1 unit to 1 unit basis.
Reviewed: 23 Oct 18 (Admelog and Admelog Solostar), February 2021 (Lyumjev)
Updated: February 24 (Admelog)
Insulin Lispro (Admelog)